Research Article

The Analysis of Dynamic Changes and Prognosis of Posner–Schlossman Syndrome with Cytomegalovirus Infection and Antiviral Therapy

Table 2

Comparison of patients from the CMV-positive and CMV-negative group.

CMV positive (N = 36)CMV negative (N = 28) value

IOP of the affected eye, mmHg24.25 ± 11.1725.57 ± 10.98
Coin-shaped KP
At the onset9/368/28
At the last visit1/361/28
ECD, cells/mm22278.45 ± 355.632557.62 ± 314.270.005
CDR0.58 ± 0.220.46 ± 0.160.017
Number of cases achieved all-KP disappearance18/3612/28
Cumulative steroids dosage, drops204.56 ± 195.67129.50 ± 125.02
Cumulative ganciclovir eye drops dosage (drops)567.00 ± 867.450
Cumulative treatment time (weeks)21.44 ± 34.6710.08 ± 7.53
Steroids dosage per day at the last visit (times/day)0.61 ± 0.780.75 ± 0.97
Number of cases exempted from steroids10/187/12

IOP = intraocular pressure. CMV = cytomegalovirus. ECD = endothelial cell density. CDR = cup-to-disc ratio. KP = keratic precipitate. Student’s t-tests.